Jpmorgan Chase & CO Schedule 13G passive stakes

JPMorgan Chase & Co. has disclosed a 5.2% beneficial ownership stake in Host Hotels & Resorts, Inc., held in the ordinary course of business.

JPMorgan Chase & Co. has disclosed a 7.9% beneficial ownership stake in Insmed Incorporated, holding over 15 million shares as of June 30, 2025.

JPMorgan Chase & Co. has reported a 5.3% beneficial ownership stake in Kite Realty Group Trust, totaling 11,707,472 common shares.

JPMorgan Chase & Co. has reported a beneficial ownership of 5.5% in Lowe's Companies, Inc., totaling over 30 million shares, held in the ordinary course of business.

JPMorgan Chase & Co. has reported a 5.0% beneficial ownership stake in Sionna Therapeutics, Inc., holding 2,221,188 shares of common stock.

JPMorgan Chase & Co. has reported a 5.0% beneficial ownership stake in Take-Two Interactive Software, Inc., totaling 9,303,967 shares of common stock.

JPMorgan Chase & Co. has reported a beneficial ownership of 5.1% in TD SYNNEX Corporation's common stock, totaling 4,218,793 shares.

JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a 6.4% beneficial ownership stake in Bright Horizons Family Solutions Inc. as of June 30, 2025.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 7.5% beneficial ownership stake in Flowco Holdings Inc.'s Class A common stock.

JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a 5.2% beneficial ownership stake in Janus International Group, Inc. as of June 30, 2025.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a beneficial ownership of 5.5% in Otis Worldwide Corporation's common stock.

JPMorgan Chase & Co. has reported a 5.6% beneficial ownership stake in Rocket Companies, Inc. Class A common stock as of June 30, 2025.

JPMorgan Chase & Co. has reported a 6.2% passive beneficial ownership stake in The Southern Company's common stock.

JPMorgan Chase & Co. has reported a 6.5% beneficial ownership stake in Yum! Brands, Inc., holding over 18 million shares as a passive investment.

JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a beneficial ownership of 9.2% in Burlington Stores, Inc. common stock as of June 30, 2025.

JPMorgan Chase & Co. has reported a beneficial ownership of 7.6% of Howmet Aerospace Inc.'s common stock, totaling over 30.9 million shares, held for investment purposes.

JPMorgan Chase & Co. has filed an amendment to its Schedule 13G, disclosing a passive beneficial ownership of 8.8% in IAC Inc.'s common stock.

JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a beneficial ownership of 7.6% in MGIC Investment Corporation's common stock as of June 30, 2025.

JPMorgan Chase & Co. has reported a 7.7% beneficial ownership stake in Natera, Inc., held passively for investment purposes.

JPMorgan Chase & Co. has reported an 8.4% beneficial ownership stake in Seagate Technology Holdings PLC, holding 17,890,283 ordinary shares as a passive investor.

JPMorgan Chase & Co. has reported a 7.9% passive beneficial ownership stake in Twilio Inc.'s Class A Common Stock as of June 30, 2025.

JPMorgan Chase & Co. has reported a 7.6% beneficial ownership stake in Yum China Holdings, Inc., holding 28.4 million shares as a passive investor.

JPMorgan Chase & Co. has filed a Schedule 13G, revealing a 5.2% beneficial ownership stake in Karyopharm Therapeutics Inc.'s common stock.

JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a beneficial ownership of 9.0% in Radiopharm Theranostics Limited's American Depositary Shares.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.7% in Vasta Platform Limited's Class A common shares.

JPMorgan Chase & Co. has disclosed a 7.5% beneficial ownership stake in Zura Bio Limited's Class A Ordinary Shares, as reported in a Schedule 13G filing.

JPMorgan Chase & Co. has filed a Schedule 13G, revealing a beneficial ownership of 6.4% in CI&T Inc.'s Class A common shares.

JPMorgan Chase & Co. has filed an amended Schedule 13G, revealing a beneficial ownership of 10.3% in Fidelity National Information Services, Inc. as of June 30, 2025.

JPMorgan Chase & Co. has filed an Amendment No. 7 to Schedule 13G, reporting a passive beneficial ownership of 0.6% in Carter's, Inc. common stock as of May 30, 2025.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting zero beneficial ownership in Intra-Cellular Therapies, Inc. as of May 30, 2025.